Virginia Retirement Systems’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.13M	Buy	79,898 +18,050	+29%	+$431K	0.01%	404
2025 Q3	$1.32M	Sell	61,848 -900	-1%	-$21.3K	0.01%	515
2025 Q2	$1.35M	Sell	62,748 -8,700	-12%	-$162K	0.01%	503
2025 Q1	$1.19M	Buy	+71,448	New	+$1.3M	0.01%	521
2023 Q3	$882K	Sell	42,300 -15,100	-26%	-$410K	0.01%	544
2023 Q2	$1.37M	Buy	57,400 +19,700	+52%	+$438K	0.01%	457
2023 Q1	$710K	Buy	37,700 +8,300	+28%	+$158K	0.01%	640
2022 Q4	$468K	Sell	29,400 -4,300	-13%	-$67.2K	﹤0.01%	845
2022 Q3	$551K	Buy	+33,700	New	+$546K	0.01%	781
2022 Q1	$862K	Sell	35,600 -2,000	-5%	-$48.4K	0.01%	693
2021 Q4	$878	Buy	37,600 +200	+0.5%	+$4.02K	0.01%	703
2021 Q3	$621K	Buy	37,400 +6,700	+22%	+$129K	0.01%	754
2021 Q2	$749K	Buy	30,700 +16,400	+115%	+$370K	0.01%	740
2021 Q1	$369K	Buy	14,300 +1,700	+13%	+$74.8K	﹤0.01%	951
2020 Q4	$674K	Sell	12,600 -15,100	-55%	-$750K	0.01%	743
2020 Q3	$1.14M	Sell	27,700 -3,000	-10%	-$130K	0.01%	511
2020 Q2	$1.49M	Buy	30,700 +3,300	+12%	+$158K	0.02%	457
2020 Q1	$1.16M	Buy	27,400 +20,900	+322%	+$861K	0.02%	495
2019 Q4	$278K	Buy	+6,500	New	+$283K	﹤0.01%	1050